Patent ID: 11883404
Assignee: TAIHO PHARMACEUTICAL CO., LTD.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 11:
12. A method for reducing body weight change in a patient undergoing treatment with an FGFR inhibitor, comprising administering an AKT inhibitor in combination with a FGFR inhibitor, wherein said AKT inhibitor is trans-3-amino-1-methyl-3-(4-(3-phenyl-5H-imidazo[1,2-c]pyrido[3,4-e][1,3]oxazin-2-yl)phenyl)cyclobutanol or a pharmaceutically acceptable salt thereof and said FGFR inhibitor is (S)-1-(3-(4-Amino-3-((3,5-dimethoxyphenyl)ethynyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)pyrrolidin-1-yl)prop-2-en-1-one or a pharmaceutically acceptable salt thereof.